STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
NeuroVive Pharmaceutical (STO:NVP):
Fourth Quarter (1 Oct. 2015 – 31 Dec. 2015)
· Net revenues were SEK 0 (0) and other operating income was SEK 23,000 (8,000).
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
NeuroVive Pharmaceutical (STO:NVP):
Fourth Quarter (1 Oct. 2015 – 31 Dec. 2015)
· Net revenues were SEK 0 (0) and other operating income was SEK 23,000 (8,000).
